Pain Archives | Page 2 of 2 | Center for U.S. Policy

FDA Advisory Committees Review New Evidence on Long-Term Opioid Risks, Prompting Labeling Updates

FDA Advisory Committees Review New Evidence on Long-Term Opioid Risks, Prompting Labeling Updates

News May 28, 2025

FDA Approves First New Pain Reliever in Over Two Decades

FDA Approves First New Pain Reliever in Over Two Decades

News February 10, 2025

DEA Issues Third Extension of Temporary Telemedicine Flexibilities

DEA Issues Third Extension of Temporary Telemedicine Flexibilities

News November 17, 2024

FDA Faces Backlash Over Approval of Test for OUD Risk

FDA Faces Backlash Over Approval of Test for OUD Risk

April 12, 2024

The Ineffectiveness of CBD for Chronic Pain Management: Consumer Safety Implications

The Ineffectiveness of CBD for Chronic Pain Management: Consumer Safety Implications

News March 20, 2024